BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31026254)

  • 21. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
    Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
    Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction.
    Huang L; Dai F; Tang L; Bao X; Liu Z; Huang C; Zhang T; Yao W
    Cell Physiol Biochem; 2018; 49(2):565-577. PubMed ID: 30165352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
    Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
    Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.
    Xi ZW; Xin SY; Zhou LQ; Yuan HX; Wang Q; Chen KX
    World J Gastroenterol; 2015 May; 21(18):5454-64. PubMed ID: 25987767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways.
    Luo Y; Wu JY; Lu MH; Shi Z; Na N; Di JM
    Oxid Med Cell Longev; 2016; 2016():1469693. PubMed ID: 27803760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rubimaillin suppresses proliferation, migration and invasion of prostate cancer cells via the Notch-1/MMP signaling pathway.
    Cai F; Guo S; Huang S; Li J; Liu W
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):130-134. PubMed ID: 32415939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
    Huang Z; Li G; Zhang Z; Gu R; Wang W; Lai X; Cui ZK; Zeng F; Xu S; Deng F
    BMC Cancer; 2019 Nov; 19(1):1142. PubMed ID: 31771535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZEB1 promotes prostate cancer proliferation and invasion through ERK1/2 signaling pathway.
    Song XF; Chang H; Liang Q; Guo ZF; Wu JW
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4032-4038. PubMed ID: 29028100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
    Huang H; Du T; Zhang Y; Lai Y; Li K; Fan X; Zhu D; Lin T; Xu K; Huang J; Liu L; Guo Z
    Prostate; 2017 May; 77(7):718-728. PubMed ID: 28230260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.
    Zhang C; Zhang S; Zhang Z; He J; Xu Y; Liu S
    Oncogene; 2014 Dec; 33(49):5582-91. PubMed ID: 24317511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing signaling of ROCK1 and ROCK2 determines the switching of substrate specificity and the mode of migration of glioblastoma cells.
    Mertsch S; Thanos S
    Mol Neurobiol; 2014 Apr; 49(2):900-15. PubMed ID: 24170433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
    Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
    Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma.
    Yu J; Shi W; Zhao R; Shen W; Li H
    Clin Transl Oncol; 2020 Dec; 22(12):2312-2323. PubMed ID: 32447646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
    Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
    Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
    Kidera Y; Tsubaki M; Yamazoe Y; Shoji K; Nakamura H; Ogaki M; Satou T; Itoh T; Isozaki M; Kaneko J; Tanimori Y; Yanae M; Nishida S
    J Exp Clin Cancer Res; 2010 Sep; 29(1):127. PubMed ID: 20843370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.